Literature DB >> 25395406

Affinities of human histo-blood group antigens for norovirus capsid protein complexes.

Ling Han1, Elena N Kitova1, Ming Tan2, Xi Jiang2, Benjamin Pluvinage3, Alisdair B Boraston3, John S Klassen4.   

Abstract

The binding profiles of many human noroviruses (huNoVs) for human histo-blood group antigens have been characterized. However, quantitative-binding data for these important virus-host interactions are lacking. Here, we report on the intrinsic (per binding site) affinities of HBGA oligosaccharides for the huNoV VA387 virus-like particles (VLPs) and the associated subviral P particles measured using electrospray ionization mass spectrometry. The affinities of 13 HBGA oligosaccharides, containing A, B and H epitopes, with variable sizes (disaccharide to tetrasaccharide) and different precursor chain types (types 1, 2, 3, 5 and 6), were measured for the P particle, while the affinities of the A and B trisaccharides and A and B type 6 tetrasaccharides for the VLP were determined. The intrinsic affinities of the HBGA oligosaccharides for the P particle range from 500 to 2300 M(-1), while those of the A and B trisaccharides and the A and B type 6 tetrasaccharides for the VLP range from 1000 to 4000 M(-1). Comparison of these binding data with those measured previously for the corresponding P dimer reveals that the HBGA oligosaccharides tested exhibit similar intrinsic affinities for the P dimer and P particle. The intrinsic affinities for the VLP are consistently higher than those measured for the P particle, but within a factor of three. While the cause of the subtle differences in HBGA oligosaccharide affinities for the P dimer and P particle and those for the VLP remains unknown, the present data support the use of P dimers or P particles as surrogates to the VLP for huNoV-receptor-binding studies.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  affinities; antigen; electrospray ionization mass spectrometry; norovirus

Mesh:

Substances:

Year:  2014        PMID: 25395406      PMCID: PMC4351396          DOI: 10.1093/glycob/cwu100

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  42 in total

1.  Synthesis of ABO histo-blood group type I and II antigens.

Authors:  Peter J Meloncelli; Todd L Lowary
Journal:  Carbohydr Res       Date:  2010-09-16       Impact factor: 2.104

2.  Norwalk virus assembly and stability monitored by mass spectrometry.

Authors:  Glen K Shoemaker; Esther van Duijn; Sue E Crawford; Charlotte Uetrecht; Marian Baclayon; Wouter H Roos; Gijs J L Wuite; Mary K Estes; B V Venkataram Prasad; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2010-04-22       Impact factor: 5.911

3.  Genetic control of the fucosylation of ABH precursor chains. Evidence for new epistatic interactions in different cells and tissues.

Authors:  R Oriol
Journal:  J Immunogenet       Date:  1990 Aug-Oct

4.  Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles.

Authors:  Ming Tan; Ping-An Fang; Ming Xia; Teepanis Chachiyo; Wen Jiang; Xi Jiang
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

5.  Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.

Authors:  A de Rougemont; N Ruvoen-Clouet; B Simon; M Estienney; C Elie-Caille; S Aho; P Pothier; J Le Pendu; W Boireau; G Belliot
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

6.  Structural basis for norovirus inhibition and fucose mimicry by citrate.

Authors:  Grant S Hansman; Syed Shahzad-Ul-Hussan; Jason S McLellan; Gwo-Yu Chuang; Ivelin Georgiev; Takashi Shimoike; Kazuhiko Katayama; Carole A Bewley; Peter D Kwong
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

7.  The overall architecture and receptor binding of pneumococcal carbohydrate-antigen-hydrolyzing enzymes.

Authors:  Melanie A Higgins; Elizabeth Ficko-Blean; Peter J Meloncelli; Todd L Lowary; Alisdair B Boraston
Journal:  J Mol Biol       Date:  2011-07-13       Impact factor: 5.469

8.  A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.

Authors:  Kirsi Tamminen; Leena Huhti; Tiia Koho; Suvi Lappalainen; Vesa P Hytönen; Timo Vesikari; Vesna Blazevic
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

9.  Interrogating viral capsid assembly with ion mobility-mass spectrometry.

Authors:  Charlotte Uetrecht; Ioana M Barbu; Glen K Shoemaker; Esther van Duijn; Albert J R Heck
Journal:  Nat Chem       Date:  2010-12-19       Impact factor: 24.427

10.  The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Rashmi S Hegde; Xi Jiang
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  11 in total

Review 1.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

2.  Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.

Authors:  Brigitte Fiege; Mila Leuthold; Francisco Parra; Kevin P Dalton; Peter J Meloncelli; Todd L Lowary; Thomas Peters
Journal:  Glycoconj J       Date:  2017-08-19       Impact factor: 2.916

3.  Human noroviruses' fondness for histo-blood group antigens.

Authors:  Bishal K Singh; Mila M Leuthold; Grant S Hansman
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

Review 4.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

5.  Antibody-based affinity cryo-EM grid.

Authors:  Guimei Yu; Kunpeng Li; Wen Jiang
Journal:  Methods       Date:  2016-01-21       Impact factor: 3.608

Review 6.  Anti-norovirus therapeutics: a patent review (2010-2015).

Authors:  Anushka C Galasiti Kankanamalage; Pathum M Weerawarna; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Expert Opin Ther Pat       Date:  2016       Impact factor: 6.674

Review 7.  Probing allosteric mechanisms using native mass spectrometry.

Authors:  Michal Sharon; Amnon Horovitz
Journal:  Curr Opin Struct Biol       Date:  2015-05-22       Impact factor: 6.809

8.  A quantitative, high-throughput method identifies protein-glycan interactions via mass spectrometry.

Authors:  Pavel I Kitov; Elena N Kitova; Ling Han; Zhixiong Li; Jaesoo Jung; Emily Rodrigues; Carmanah D Hunter; Christopher W Cairo; Matthew S Macauley; John S Klassen
Journal:  Commun Biol       Date:  2019-07-22

9.  Norovirus-glycan interactions - how strong are they really?

Authors:  Thomas Peters; Robert Creutznacher; Thorben Maass; Alvaro Mallagaray; Patrick Ogrissek; Stefan Taube; Lars Thiede; Charlotte Uetrecht
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

Review 10.  Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.

Authors:  Souvik Ghosh; Yashpal Singh Malik; Nobumichi Kobayashi
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.